Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Torii gets Japanese marketing rights to HIV therapy from parent Japan Tobacco

Executive Summary

Japan Tobacco Inc. has licensed its Japanese pharma subsidiary Torii Pharmaceutical Co. Ltd. exclusive rights to market a single-tablet HIV treatment containing JTK303 (elvitegravir) in Japan.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register